Derek Cowsert

News

TP53 Alterations Predict Rapid Treatment Resistant Evolution in Patients With EFGR-Mutated NSCLC

08/09/2022

Study findings reveal TP53 alterations were associated with rapid progression of treatment resistance evolution regardless of treatment mechanism in patients with EFGR-mutated NSCLC.

Study findings reveal TP53...

08/09/2022

Oncology

News

Mirvetuximab Soravtansine Demonstrates Safety, Efficacy in Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression

02/07/2023

Derek Cowsert ;

Study findings show mirvetuximab soravtansine yields promising results in efficacy and safety among patients with high folate receptor alpha expressing platinum-resistant ovarian cancer.

Study findings show mirvetuximab...

02/07/2023

Oncology

News

Adjuvant Durvalumab Efficacy for Non-Small Cell Lung Cancer With Mutations

05/10/2023

Derek Cowsert ;

A study explored the efficacy of adjuvant durvalumab for patients with stage 3 unresectable non-small cell lung cancer and KRAS mutations, as well as uncommon driver genomic alterations.

A study explored the efficacy of...

05/10/2023

Oncology

News

Pembrolizumab Associated With Survival Benefit Among Patients With NSCLC and Smoking History

06/13/2022

Derek Cowsert ;

Study findings suggest first-line pembrolizumab yielded consistently longer OS among patients with NSCLC and a history of smoking than those with no smoking history.

Study findings suggest...

06/13/2022

Oncology

News

Certain Tumor Microenvironment Factors Associated With Durable Clinical Benefit From Immune Checkpoint Inhibitor Therapy for Extensive Stage SCLC

10/12/2022

Derek Cowsert ;

A retrospective study identified multiple factors associated with durable clinical benefit in patients with extensive stage small-cell lung cancer being treated with immune checkpoint inhibitors and chemotherapy.

A retrospective study identified...

10/12/2022

Oncology

News

Lenvatinib Plus Pembrolizumab Demonstrates Long-Term Efficacy, Safety in Advanced Endometrial Carcinoma

02/16/2023

Derek Cowsert ;

Updated study results find lenvatinib plus pembrolizumab exhibits long-term safety and efficacy for patients with previously treated advanced endometrial carcinoma.

Updated study results find...

02/16/2023

Oncology

News

16a-[18F]Fluoro-17b-Estradiol Molecular Imaging Demonstrates Clinical Validity in Assessing ER Status in Metastatic Breast Cancer

07/12/2022

Derek Cowsert ;

Findings from a prospective multicenter trial show the validity of [18F]FES-PET whole body imaging for assessing the immunohistochemistry of an ER status of a metastasis biopsy for patients with metastatic breast cancer.

Findings from a prospective...

07/12/2022

Oncology

News

FDA Grants Accelerated Approval to Mirvetuximab Soravtansine for FRα-Positive, Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

11/15/2022

Derek Cowsert ;

On November 14, 2022, the FDA approved mirvetuximab soravtansine-gynx, administered intravenously every 3 weeks, for adult patients with folate receptor alpha-positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal...

On November 14, 2022, the FDA...

11/15/2022

Oncology

News

PD-L1 Score Demonstrates Value as Prognostic Biomarker in Early-Stage EGFR-Mutated Non-Small Cell Lung Cancer

01/18/2023

Derek Cowsert ;

Study finds PD-L1 scores exhibit value in predicting survival rates in patients with early stage EFGR-mutated non-small cell lung cancer.

Study finds PD-L1 scores exhibit...

01/18/2023

Oncology

News